Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
From MaRDI portal
Recommendations
- Screening for a chronic disease: a multiple stage duration model with partial observability
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- Estimation of disease prevalence from a screening program
- Diagnostic and sampling models in screening
- An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
- Estimating case-fatality reduction from randomized screening trials
- Rate estimation from prevalence information on a simple epidemiologic model for health interventions
- Mortality Modeling of Early Detection Programs
Cited in
(48)- An age dependent stochastic model of periodic screening: Basic properties
- Theoretical study of retinoblastoma in the hereditary and non-hereditary processes including the cancer growth
- Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
- An optimal design for simple illness-death model
- A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening
- Early detection of disease and scheduling of screening examinations
- Identifiability of the joint distribution of age and tumor size at detection in the presence of screening
- MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
- Estimating distribution of the age of onset of detectable asymptomatic cancer
- A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring
- A stochastic model for calibrating the survival benefit of screen-detected cancers
- Diagnostic and sampling models in screening
- Scheduling optimal examination times in a simple illness-death model
- A review of estimation of key parameters and lead time in cancer screening
- Gamma process-based models for disease progression
- Treatment comparisons with screenable endpoints.
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- Proportional Hazards Regression for Cancer Studies
- How well can screening sensitivity and sojourn time be estimated
- Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers
- The Natural History of Lung Cancer in a Periodically Screened Population
- Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers
- Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing
- Quantifying overdiagnosis for multicancer detection tests: a novel method
- Inference of long term effects and overdiagnosis in periodic cancer screening
- scientific article; zbMATH DE number 3956291 (Why is no real title available?)
- Modeling the overdetection of screen-identified cancers in population-based cancer screening with the Coxian phase-type Markov process
- Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups
- Screening for a chronic disease: a multiple stage duration model with partial observability
- A Note on the Sensitivities of Self-reporting and Screen Detection of Primary Breast Tumours
- On the application of mathematical models in maintenance
- A Conditional Approach to Measure Mortality Reductions Due to Cancer Screening
- Modelling multi-stage processes through multivariate distributions
- The genetics of breast and ovarian cancer. IV: A model of breast cancer progression
- Generalized poisson regression model
- Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
- On the optimal policies of cancer screening
- Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
- Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
- Multivariate distributions of clinical covariates at the time of cancer detection
- A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection
- Quantification of length-bias in screening trials with covariate-dependent test sensitivity
- Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
- HCViewer: software and technology for quality control and processing raw mass data of preventive screening
- Screening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherence
- Bayesian Inference for the Lead Time in Periodic Cancer Screening
- Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time
- Dynamic forecasting and control algorithms of glaucoma progression for clinician decision support
This page was built for publication: Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3317956)
